Preleukemic AML1/ETO-expressing hematopoietic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation; Evidence for multistep leukemogenesis.

被引：0
|
作者：
Miyamoto, T
Weissman, IL
Akashi, K
机构：
[1] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3057
引用
收藏
页码：691A / 691A
页数：1
相关论文
共 50 条
  • [1] AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation
    Miyamoto, T
    Weissman, IL
    Akashi, K
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) : 7521 - 7526
  • [2] DETECTION OF THE AML1/ETO FUSION TRANSCRIPT IN THE T(8-21) MASKED TRANSLOCATION IN ACUTE MYELOGENOUS LEUKEMIA
    MARUYAMA, F
    YANG, PR
    STASS, SA
    CORK, A
    FREIREICH, EJ
    LEE, MS
    CHANG, KS
    CANCER RESEARCH, 1993, 53 (19) : 4449 - 4451
  • [3] Characterization of the ETO and AML1-ETO proteins involved in the 8;21 translocation in acute myelogenous leukemia
    Le, XF
    Claxton, D
    Kornblau, S
    Fan, YH
    Mu, ZM
    Chang, KS
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1998, 60 (04) : 217 - 225
  • [4] Significance of quantitative analysis of AML1/ETO transcripts in peripheral blood stem cells from t(8;21) acute myelogenous leukemia
    Miyamoto, T
    Nagafuji, K
    Harada, M
    Niho, Y
    LEUKEMIA & LYMPHOMA, 1997, 25 (1-2) : 69 - 75
  • [5] The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFα2 transcription factor
    McNeil, S
    Zeng, CM
    Harrington, KS
    Hiebert, S
    Lian, JB
    Stein, JL
    van Wijnen, AJ
    Stein, GS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) : 14882 - 14887
  • [6] Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia
    Miyamoto, T
    Nagafuji, K
    Akashi, K
    Harada, M
    Kyo, T
    Akashi, T
    Takenaka, K
    Mizuno, S
    Gondo, H
    Okamura, T
    Dohy, H
    Niho, Y
    BLOOD, 1996, 87 (11) : 4789 - 4796
  • [7] PCR DETECTION OF THE AML1/ETO FUSION TRANSCRIPT IN ACUTE MYELOGENOUS LEUKEMIA (AML) CONTAINING THE (8 21)(Q22 Q22) TRANSLOCATION
    DOWNING, JR
    HEAD, DR
    RAIMONDI, SC
    BEHM, FG
    CARROLL, AJ
    CURCIOBRINT, AM
    ERICKSON, P
    DRABKIN, HA
    LABORATORY INVESTIGATION, 1993, 68 (01) : A89 - A89
  • [8] Leukemia-associated AML1/ETO (8;21) chromosomal translocation protein increases the cellular representation of PML bodies
    McNeil, S
    Javed, A
    Harrington, KS
    Lian, JB
    Stein, JL
    van Wijnen, AJ
    Stein, GS
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2000, 79 (01) : 103 - 112
  • [9] Identification of ins(8;21) with AML1/ETO fusion in acute myelogenous leukemia M2 by molecular cytogenetics
    Urioste, M
    Martínez-Ramírez, A
    Cigudosa, JC
    Mateo, MS
    Martínez, P
    Contra, T
    Benítez, J
    CANCER GENETICS AND CYTOGENETICS, 2002, 133 (01) : 83 - 86
  • [10] The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFA2 transcription factor.
    McNeil, S
    Zeng, C
    Harrington, K
    Hiebert, S
    Lian, JB
    Stein, JL
    van Wijnen, AJ
    Stein, GS
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 291A - 291A
12345